Carl Zeiss Meditec
Axial Length Measurements Can Be Accurately Calculated in Less Time
DUBLIN, CA (November 8, 2010) – Carl Zeiss Meditec today announced that the IOLMaster® 500,
the newest biometer used to calculate all necessary eye measurements for optimal lens selection
for cataract surgery procedures, has received marketing clearance from the U.S. Food and Drug
Administration. With dual measurement capabilities, composite signal filtering and user-interface
advancements, the IOLMaster 500 is now twice as fast as previous platforms and increases the
percentage of measurable eyes, even for patients with dense cataracts.
"Since we introduced the first IOLMaster to the ophthalmic community more than a decade ago,
we have continued to incorporate features that optimize ease-of-use and clinical outcomes," said
Ludwin Monz, CEO of Carl Zeiss Meditec. "Today, we are pleased to offer the newest and most
advanced IOLMaster, which incorporates new algorithms and user-friendly enhancements,
resulting in greater efficiency, clinical accuracy and overall performance."
Launched in 2000, the IOLMaster was the first automatic biometry system available which did not
make contact with the patient’s eye. There are now more than 11,000 units in the world today,
making the IOLMaster® the Gold Standard for cataract biometry. The new IOLMaster 500 features
several advanced new capabilities, including:
- Increased Speed: In individual practice studies, the new IOLMaster 500 has been shown
to complete all measurements in as few as 80 seconds*.
- Dual-mode Measurements: Axial length and keratometry calculations can be collected
simultaneously, at the push of a button.
- Composite Signal Filtering: New sound filtering technology excludes poor readings and
increases the percentage of cataract patients that can be measured.
- Seamless Data Integration with the Synergy Ultrasound A-scan: This time-saving
feature allows easy workflow integration of A-scan ultrasound biometry for difficult cases,
such as extremely dense cataracts.
- Easy Data Transfer to the Holladay Consultant Program: The Holladay II formula has
become very popular among physicians in North America.
- New Graphical User Interface: With green, red and yellow "traffic light" reporting,
technicians of all experience levels can achieve highly accurate diagnostic results.
Collectively, these enhancements allow physicians and their technicians to achieve accurate axial
length measurements for more patients than ever before, while significantly reducing
measurement time.
"Anything that improves patient outcomes in cataract surgery is a win-win for the physician and for
the patient," said Alice Epitropoulos, MD, Co-Founder of the Eye Center of Columbus and
Assistant Clinical Professor at The Ohio State University. "The IOLMaster 500 not only has a
higher success rate of measuring axial length in dense cataracts but it also provides the most
accurate axial length readings, resulting in expected post-surgical visual outcomes. This new
platform significantly improves accuracy, speed and convenience in my practice while giving me
confidence in determining the best post-surgical outcomes for my patients."
Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is
one of the world’s leading medical technology companies.
The Company supplies innovative technologies and application-oriented solutions which enable doctors to
improve the quality of life of their patients. The Company offers complete solutions, including implants and
consumables, to diagnose and treat ophthalmic diseases. In the field of Neuro/ENT surgery, the Company
provides innovative visualization solutions. Carl Zeiss Meditec's medical technology portfolio is rounded off by
promising future technologies such as intraoperative radiotherapy.
The Company's approximately 2,100 employees generated revenue of about EUR 600 million in fiscal year
2007/08 (ended Sept. 30). The headquarters of Carl Zeiss Meditec are located in Jena, Germany. In addition
to other subsidiaries in Germany, the Company is represented by over 50 percent of its employees at sites in
the USA, Japan, Spain and France.
Thirty-five percent of Carl Zeiss Meditec’s shares are in free float. The remaining 65 percent are held by Carl
Zeiss AG, one of the world’s leading groups engaged in the optical and opto-electronics industry. The five
independently run business segments of Carl Zeiss AG operate in the future-oriented markets "Medical and
Research Solutions," "Industrial Solutions" and "Lifestyle Products." Carl Zeiss AG is headquartered in
Oberkochen, Germany. During fiscal year 2007/08 (ended Sept. 30) the company generated revenues of
about EUR 2.7 billion. Carl Zeiss has around 13,000 employees in more than 30 countries, including more
than 8,000 in Germany.
For further information please visit our website at: www.meditec.zeiss.com
Contact:
Eva Sesselmann
Director Group Communications
Carl Zeiss Meditec AG
Göschwitzer Strasse 51-52
07745 Jena
Telefon: +49 3641 220-331
Telefax: +49 3641 220-332
Email: [email protected]
Carmen Caricchio
President
CoActive Health Communications
2600 18th Street, Suite 21
San Francisco, CA 94110
Telephone: +415 621-6626
Fax: +415 621-6636
Email: [email protected]